NFA
FURX

Nationwide Fund Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Nationwide Fund Advisors’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,503
Closed -$584K – 3421
2014
Q2 		$584K Buy
5,503
+379
+7% +$37.2K ﹤0.01% 2179
2014
Q1 		$446K Sell
5,124
-264
-5% -$20.4K ﹤0.01% 2106
2013
Q4 		$226K Sell
5,388
-83
-2% -$3.41K ﹤0.01% 2632
2013
Q3 		$241K Sell
5,471
-117
-2% -$4.84K ﹤0.01% 2572
2013
Q2 		$190K Buy
+5,588
New +$196K ﹤0.01% 2511

Nationwide Fund Advisors's FURX Position: Q3 2014 in Review

Nationwide Fund Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 5,503 shares — an estimated $584K sold.

Nationwide Fund Advisors first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $584K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Nationwide Fund Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Nationwide Fund Advisors sold 5,503 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $584K.
  • Nationwide Fund Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Nationwide Fund Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $584K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Nationwide Fund Advisors's 13F filing for Q3 2014, filed 7 Nov 2014.